Mouse embryonic stem cells (ESCs) grown in serum-supplemented conditions are characterized by an extremely short G1 phase due to the lack of G1-phase control. Concordantly, the G1-phase-specific P53-P21 pathway is compromised in serum ESCs. Here, we provide evidence that P53 is activated upon transition of serum ESCs to their pluripotent ground state using serum-free 2i conditions and that is required for the elongated G1 phase characteristic of ground state ESCs. RNA sequencing and chromatin immunoprecipitation sequencing analyses reveal that P53 directly regulates the expression of the retinoblastoma (RB) protein and that the hypo-phosphorylated, active RB protein plays a key role in G1-phase control. Our findings suggest that the P53-P21 pathway is active in ground state 2i ESCs and that its role in the G1-checkpoint is abolished in serum ESCs. Taken together, the data reveal a mechanism by which inactivation of P53 can lead to loss of RB and uncontrolled cell proliferation.
机构:
Kyushu Univ, Med Inst Bioregulat, Div Mol & Clin Genet, Fukuoka 812, JapanKyushu Univ, Med Inst Bioregulat, Div Mol & Clin Genet, Fukuoka 812, Japan
Liao, Jiyuan
Kohara, Hiroshi
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokyo, Inst Med Sci, Project Div ALA Adv Med Res, Tokyo, JapanKyushu Univ, Med Inst Bioregulat, Div Mol & Clin Genet, Fukuoka 812, Japan
Kohara, Hiroshi
Nagai, Yoko
论文数: 0引用数: 0
h-index: 0
机构:
Kyushu Univ, Med Inst Bioregulat, Div Mol & Clin Genet, Fukuoka 812, JapanKyushu Univ, Med Inst Bioregulat, Div Mol & Clin Genet, Fukuoka 812, Japan
Nagai, Yoko
Marumoto, Tomotoshi
论文数: 0引用数: 0
h-index: 0
机构:
Kyushu Univ, Med Inst Bioregulat, Div Mol & Clin Genet, Fukuoka 812, Japan
Kyushu Univ Hosp, Dept Adv Mol & Cell Therapy, Fukuoka 812, JapanKyushu Univ, Med Inst Bioregulat, Div Mol & Clin Genet, Fukuoka 812, Japan
Marumoto, Tomotoshi
Tani, Kenzaburo
论文数: 0引用数: 0
h-index: 0
机构:
Kyushu Univ, Med Inst Bioregulat, Div Mol & Clin Genet, Fukuoka 812, Japan
Univ Tokyo, Inst Med Sci, Project Div ALA Adv Med Res, Tokyo, Japan
Kyushu Univ Hosp, Dept Adv Mol & Cell Therapy, Fukuoka 812, JapanKyushu Univ, Med Inst Bioregulat, Div Mol & Clin Genet, Fukuoka 812, Japan